Choice of either beta-catenin or Groucho/TLE as a co-factor for Xtcf-3 determines dorsal-ventral cell fate of diencephalon during Xenopus development.
Co-repressor Groucho/Transducin-Like Enhancer of split (TLE) interacts with transcription factors that are expressed in the central nervous system (CNS), and regulates transcriptional activities. In this study, we examined the contribution of Groucho/TLE to CNS development in Xenopus. The functional inhibition of Groucho/TLE using the WRPW motif as a competitor resulted in the conversion of the ventral cell into the dorsal fate in the prospective diencephalon. We also found that the neural plate was expanded laterally without inhibiting neural crest development. In tailbud, the disturbance of trigeminal ganglion development was observed. These observations allow us to conclude that Groucho/TLE plays important roles in the induction and patterning of distinct CNS territories. We found that Xtcf-3 is involved in some of the patterning in these territories. We generated the variant of Xtcf-3, Xtcf-3BDN-, which is suspected to interfere with the interaction between endogenous Groucho/TLE and Xtcf-3. The transcriptional activation of the Xtcf-3-target genes in response to endogenous Wnt/beta-catenin signaling by the overexpression of Xtcf-3BDN- led to a reduction of the ventral diencephalon. This result indicates that transcriptional repression by the Groucho/TLE-Xtcf-3 complex is important for ventral diencephalon patterning. This idea is supported by the finding that the overexpression of the dominant-negative form of Xtcf-3 or axil causes the expansion of the ventral diencephalon. Based on these data, we propose that the localized activation of Wnt/beta-catenin signaling, which converts Tcf from a repressor to an activator, is required for the establishment of dorsal-ventral patterning in the prospective diencephalon.
Tsuji
Saori
S
Department of Biology, Graduate School of Science, Osaka University, Machikaneyama, Toyonaka, Osaka, 560-0043, Japan.
Hashimoto
Chikara
C
D020816:Amino Acid Motifs; D000818:Animals; D019521:Body Patterning; D019070:Cell Lineage; D056970:Co-Repressor Proteins; D004027:Diencephalon / Q000166:cytology* / Q000196:embryology; D004625:Embryo, Nonmammalian / Q000166:cytology; D005124:Eye Abnormalities; D008954:Models, Biological; D011485:Protein Binding; D012097:Repressor Proteins / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism*; D051820:TCF Transcription Factors / Q000378:metabolism*; D058127:Transcription Factor 3; D058125:Transcription Factor 7-Like 1 Protein; D014981:Xenopus / Q000196:embryology*; D029867:Xenopus Proteins / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism*; D051176:beta Catenin / Q000378:metabolism*
D056970:Co-Repressor Proteins; D012097:Repressor Proteins; D051820:TCF Transcription Factors; C523700:TLE4 protein, Xenopus; C544917:Tcf3 protein, Xenopus; D058127:Transcription Factor 3; D058125:Transcription Factor 7-Like 1 Protein; D029867:Xenopus Proteins; D051176:beta Catenin